BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33064372)

  • 1. Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Yamamoto K; Shiomi H; Morimoto T; Takeji Y; Yoshikawa Y; Natsuaki M; Watanabe H; Tada T; Tazaki J; Yamaji K; Tamura T; Ando K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T
    Catheter Cardiovasc Interv; 2021 May; 97(6):E758-E770. PubMed ID: 33064372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Coronary Intervention Complexity and Risk of Adverse Events in relation to High Bleeding Risk among Patients Receiving Drug-Eluting Stents: Insights from a Large Single-Center Cohort Study.
    Wang HY; Wang Y; Yin D; Gao RL; Yang YJ; Xu B; Dou KF
    J Interv Cardiol; 2020; 2020():2985435. PubMed ID: 32405273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Body Weight on Bleeding and Ischemic Events in Patients Undergoing Percutaneous Coronary Intervention - From the CREDO-Kyoto Registry Cohort-2.
    Yamamoto K; Natsuaki M; Yoshikawa Y; Morimoto T; Shiomi H; Watanabe H; Kato T; Saito N; Kadota K; Ando K; Furukawa Y; Tamura T; Sakamoto H; Toyofuku M; Inada T; Inoko M; Suwa S; Onodera T; Ishii K; Kanamori N; Kimura T;
    Circ J; 2020 Sep; 84(10):1734-1745. PubMed ID: 32893236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB; Marso SP; Pencina M; Stolker JM; Kennedy KF; Rihal C; Barsness G; Piana RN; Goldberg SL; Cutlip DE; Kleiman NS; Cohen DJ;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1074-82. PubMed ID: 19926047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.
    Costa F; Van Klaveren D; Feres F; James S; Räber L; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M;
    J Am Coll Cardiol; 2019 Feb; 73(7):741-754. PubMed ID: 30784667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention versus coronary arterial bypass grafting in patients with multi-vessel coronary revascularization (from the CREDO-Kyoto PCI/CABG registry/cohort-2).
    Watanabe H; Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Tazaki J; Watanabe H; Natsuaki M; Minatoya K; Hanyu M; Komiya T; Kimura T;
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):42-51. PubMed ID: 31389659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Natsuaki M; Takeji Y; Watanabe H; Yoshikawa Y; Matsumura-Nakano Y; Shizuta S; Tanabe K; Ando K; Kadota K; Morino Y; Kozuma K; Nakagawa Y; Kimura T
    Am J Cardiol; 2020 Feb; 125(3):399-408. PubMed ID: 31771755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
    Tokushige A; Shiomi H; Morimoto T; Ono K; Furukawa Y; Nakagawa Y; Kadota K; Ando K; Shizuta S; Tada T; Tazaki J; Kato Y; Hayano M; Abe M; Hamasaki S; Ohishi M; Nakashima H; Mitsudo K; Nobuyoshi M; Kita T; Imoto Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ Cardiovasc Interv; 2014 Aug; 7(4):482-91. PubMed ID: 25074253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Piccolo R; Leone A; Simonetti F; Avvedimento M; Angellotti D; Manzi L; Verde N; Spaccarotella CAM; Di Serafino L; Cirillo P; Gargiulo G; Fortunato G; Franzone A; Esposito G
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):212-220. PubMed ID: 37337462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic and Bleeding Risk After Percutaneous Coronary Intervention in Patients With Prior Ischemic and Hemorrhagic Stroke.
    Natsuaki M; Morimoto T; Watanabe H; Nakagawa Y; Furukawa Y; Kadota K; Akasaka T; Hanaoka KI; Kozuma K; Tanabe K; Morino Y; Muramatsu T; Kimura T;
    J Am Heart Assoc; 2019 Nov; 8(22):e013356. PubMed ID: 31701821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of PARIS and CREDO-Kyoto Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients With Acute Myocardial Infarction.
    Yamashita D; Saito Y; Sato T; Matsumoto T; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    Circ J; 2022 Mar; 86(4):622-629. PubMed ID: 34588393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
    Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
    Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Combinations of the Patterns of Non-adherence to Anti-platelet Regimen in Stented Patients (PARIS) and Coronary Revascularization Demonstrating Outcome Study in Kyoto (CREDO-Kyoto) Thrombotic and Bleeding Risk Scores on Clinical Outcomes in Patients with Acute Myocardial Infarction.
    Yamashita D; Saito Y; Sato T; Matsumoto T; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    Intern Med; 2024 Feb; 63(4):475-480. PubMed ID: 37344423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Acute Coronary Syndrome and Stable Coronary Artery Disease on Bleeding and Ischemic Risk After Percutaneous Coronary Intervention.
    Natsuaki M; Morimoto T; Shiomi H; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Watanabe H; Yamamoto K; Imada K; Domei T; Yamaji K; Kaneda K; Taniguchi R; Ehara N; Nawada R; Toyofuku M; Shinoda E; Suwa S; Tamura T; Inada T; Matsuda M; Aoyama T; Sato Y; Furukawa Y; Ando K; Nakagawa Y; Kimura T;
    Circ J; 2021 Oct; 85(11):1928-1941. PubMed ID: 33907052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major Predictors of Long-Term Clinical Outcomes After Percutaneous Coronary Intervention for Coronary Bifurcation Lesions With 2-Stent Strategy: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts.
    Song PS; Song YB; Lee JM; Hahn JY; Choi SH; Choi JH; Lee SH; Park KW; Kim HS; Jang Y; Seung KB; Oh JH; Gwon HC
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1879-86. PubMed ID: 27592016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding Outcomes After Percutaneous Coronary Intervention in the Past Two Decades in Japan - From the CREDO-Kyoto Registry Cohort-2 and Cohort-3.
    Natsuaki M; Morimoto T; Shiomi H; Yamamoto K; Yamaji K; Watanabe H; Uegaito T; Matsuda M; Tamura T; Taniguchi R; Inoko M; Mabuchi H; Takeda T; Domei T; Shirotani M; Ehara N; Eizawa H; Ishii K; Tanaka M; Inada T; Onodera T; Nawada R; Shinoda E; Yamada M; Yamamoto T; Sakai H; Toyofuku M; Tamura T; Takahashi M; Tada T; Sakamoto H; Tada T; Kaneda K; Miki S; Aoyama T; Suwa S; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Circ J; 2022 Apr; 86(5):748-759. PubMed ID: 34526432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Circ J; 2015; 79(6):1282-9. PubMed ID: 25818902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Yamamoto K; Shiomi H; Morimoto T; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Imada K; Domei T; Kaneda K; Taniguchi R; Ehara N; Nawada R; Natsuaki M; Yamaji K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T;
    Am J Cardiol; 2021 Apr; 145():47-57. PubMed ID: 33454345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.